IRADIMED CORPORATION reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 17.6 million compared to USD 15.48 million a year ago. Net income was USD 4.14 million compared to USD 3.41 million a year ago.

Basic earnings per share from continuing operations was USD 0.33 compared to USD 0.27 a year ago. Diluted earnings per share from continuing operations was USD 0.32 compared to USD 0.27 a year ago.